Goldman Sachs’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Goldman Sachs’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-571,610	Closed	-$19.7M	–	7569
2014 Q4	$19.7M	Sell	571,610 -16,317	-3%	-$532K	0.01%	1826
2014 Q3	$17.6M	Buy	587,927 +350,193	+147%	+$7.42M	0.01%	1893
2014 Q2	$4.77M	Sell	237,734 -195,649	-45%	-$4.49M	﹤0.01%	3099
2014 Q1	$11.8M	Buy	433,383 +187,985	+77%	+$4.99M	﹤0.01%	2226
2013 Q4	$5.09M	Buy	245,398 +29,089	+13%	+$548K	﹤0.01%	3063
2013 Q3	$3.94M	Buy	216,309 +53,905	+33%	+$974K	﹤0.01%	3199
2013 Q2	$2.7M	Buy	+162,404	New	+$2.59M	﹤0.01%	3402

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs's AUXL Position: Q1 2015 in Review

Goldman Sachs sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 571,610 shares — an estimated $19.7M sold.

Goldman Sachs first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $19.7M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Goldman Sachs reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 571,610 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $19.7M.
Goldman Sachs first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Goldman Sachs's AUXILIUM PHARAMCEUTICALS INC position peaked at $19.7M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.